Eledon Pharmaceuticals, Inc.
ELDN· Nasdaq
Released Aug 11, 2022, after the close
10-Q filed Aug 11, 2022, 42 days after period end · 0000950170-22-016935
| Metric | Q2 2022 | Q2 2021 | Q2 2020 | Q2 2019 |
|---|---|---|---|---|
| Net Income | -$9.25M | -$7.38M | -$2.59M | -$4.09M |
| EPS Diluted | -$0.65 | -$0.50 | -$2.74 | -$0.35 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Eledon Pharmaceuticals, Inc. · CIK 1404281 · Engraved from SEC EDGAR